SCHEMBL5862775

SCHEMBL5862775

COC(=O)c1sc(-c2ccc(C(F)(F)F)cc2)cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.52
CCR1 P32246 1/20 0.50
KDM4E B2RXH2 8/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
NPSR1 Q6W5P4 4/20 0.48
MAPK1 P28482 2/20 0.48
CISD2 Q8N5K1 1/20 0.47
HPGD P15428 1/20 0.46
CRHBP P24387 3/20 0.46
CRHR2 Q13324 3/20 0.46
GFER P55789 1/20 0.46
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5860688 0.86 MAPT (0.59) CCR1KDM4EMAPTNPC1CASP3
SCHEMBL23452097 0.85 NPSR1 (0.56) IKBKBKDM4EMAPTNPC1CASP3
SCHEMBL3960511 0.84 CCR1 (0.50) CCR1KDM4EMAPTNPC1NPSR1
SCHEMBL5860808 0.84 CCR1 (0.50) CCR1KDM4EMAPTNPC1CRHBP
SCHEMBL5860633 0.82 IKBKB (0.51) IKBKBKDM4EMAPTNPC1CASP3
SCHEMBL12530234 0.81 MAPT (0.72) IKBKBCCR1KDM4EMAPTNPC1
SCHEMBL1724059 0.81 MAPT (0.65) IKBKBKDM4EMAPTNPC1CASP3
SCHEMBL28941594 0.81 IKBKB (0.50) IKBKBKDM4EMAPTNPC1CASP3
SCHEMBL28941592 0.80 IKBKB (0.46) IKBKBCCR1KDM4EMAPTNPC1
SCHEMBL3952839 0.78 CCR1 (0.41) IKBKBCCR1KDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091237-B2 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2006-08-15 US disclosed
EP-1392674-B1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-08-10 EP disclosed
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors GLAXO GROUP LIMITED (GB) 2004-08-12 US disclosed
CN-1507442-A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors 2004-06-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors PPARG, PPARD, PPARA IKBKB 2870/4885CCR1 1917/4885KDM4E 4485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.